Avails Medical Is Building Momentum in the Fight Against Antibiotic Resistance
Antibiotic resistance is one of the biggest challenges in modern healthcare. When bacteria stop responding to antibiotics, infections become harder to treat, leading to longer hospital stays, higher costs, and increased risk for patients.
This is where Avails Medical is stepping in—with technology designed to help doctors quickly determine which antibiotics will actually work.
What Makes Avails Medical Different?
Avails Medical has developed a diagnostic platform that delivers faster and more accurate results compared to traditional methods.
At the center of this platform is eQUANT, a system that helps clinicians identify effective treatments sooner, giving patients a better chance at recovery.
In 2024, eQUANT received clearance from the U.S. Food and Drug Administration through its 510(k) pathway, a key milestone that confirms the system meets safety and performance standards.
Now in Use at Johns Hopkins
The technology is already making its way into real clinical settings. eQUANT is currently being used at Johns Hopkins, one of the most respected healthcare institutions in the world.
Even more encouraging, the Johns Hopkins team plans to present multiple research posters and a talk at ASM Microbe 2026. This level of academic engagement signals growing confidence in the platform’s real-world impact.
Expanding Capabilities with Faster Workflows
Avails Medical isn’t stopping with one solution.
The company is expanding eQUANT’s capabilities by integrating it with rapid identification tools like MALDI-TOF, a widely used method for identifying microorganisms. This combination could further reduce the time it takes to diagnose infections and start the right treatment.
Early results from these efforts are promising and suggest even broader applications in the future.
What’s Next: The eAST System
In addition to eQUANT, Avails Medical is developing eAST, a next-generation system focused on rapid antibiotic susceptibility testing.
The goal is simple but powerful: deliver results even faster. By improving algorithms and optimizing workflows, eAST aims to shorten the time doctors need to make critical treatment decisions.
This could be especially impactful in urgent care settings where every hour matters.
Designed for Real-World Healthcare Settings
One of the standout features of Avails Medical’s technology is its accessibility.
Unlike many advanced diagnostic systems that are large and expensive, eQUANT is designed to be compact and cost-effective. This makes it suitable not just for major hospitals, but also for smaller and community healthcare facilities.
In a field where speed and access can directly impact patient outcomes, this design choice is a major advantage.
Growing Interest from Strategic Partners
As the technology continues to mature, Avails Medical is attracting attention from potential strategic partners.
This growing interest reflects both the strength of the platform and the scale of the problem it addresses. Antibiotic resistance is a global issue, and solutions that can improve treatment decisions are in high demand.
Why This Matters
The work Avails Medical is doing goes beyond innovation—it has real implications for patients and healthcare providers.
Faster, more accurate diagnostics can:
- Help doctors prescribe the right antibiotics sooner
- Reduce unnecessary antibiotic use
- Improve patient outcomes
- Combat the growing threat of antimicrobial resistance
As Avails Medical continues to advance its platform, it is positioning itself as a key player in the future of infectious disease diagnostics.
